Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

NCT05467033 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.

NCT NCT05467033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Lead sponsor
Medical University of Bialystok
Phase
Phase 3
Overall status
Recruiting
Start date
September 1, 2022
Completion date
August 31, 2026
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney biopsy